Brian Richards Psy.D.

Brian D. Richards, Psy.D. completed a Masters degree in Existential-Phenomenological Psychology at Duquesne University, a Psy.D. at the University of Denver School for Professional Psychology, and a Postdoctoral Fellowship at the Johns Hopkins Behavioral Pharmacology Research Unit (now the Center for Psychedelic and Consciousness Research), where he contributed to some of the original research administering psilocybin with cancer patients and healthy normal adults.  Dr. Richards was formerly a Clinical Director with MedOptions, a national psychiatry & behavioral health company.  He now cares for patients with a cancer diagnosis at Maryland Oncology Hematology, Aquilino Cancer Center, and with Gladstone Psychiatry and Wellness, a multisite psychiatry and specialty behavioral health practice in Maryland, where he is co-leading Experiential Medicine therapies.  Dr. Richards has worked on clinical trials with LSD, psilocybin, and MDMA.  He also teaches and mentors students at the California Institute for Integral Studies, the leading Psychedelic Medicine Certificate Program worldwide.  He is a Subject Matter Expert on Psilocybin with the Board of Psychedelic Medicine and Therapies, and has worked with BrainFutures on Coding and Reimbursement for Psychedelic-Assisted Therapy.  He currently serves on the Advisory Board of Sabba, helping to create the “Grand Unified Field” of perspectives and trainings in experiential medicine worldwide with Native AI.

 

Dr. Richards was a Lead Psychologist on an innovative, simultaneous high-dose group administration psilocybin trial with cancer patients at the Bill Richards Center for Healing in Rockville, Maryland; a cutting-edge, purpose-built psychedelic medicine clinic in The Aquilino Cancer Center.  His focal work currently is with Gladstone Psychiatry and Wellness, an innovative, multisite practice delivering KAP covered by insurance.  Innovating this model is the tip of the spear to provide safe, accessible, affordable, high-quality care in outpatient health care systems.  This model incorporates Advanced Screening, similar to comprehensive labs in Primary Care, to ensure patients are safely screened and meaningfully prepared for Experiential Medicine.  

 

Dr. Richards’ clinical and research interests include meaning-centered psychotherapy, mystical experience, brain science-based approaches to vibrant health and wellness, and working with treatment refractory patients. He finds joy and meaning practicing yoga, studying the Upanishads, The Bhagavad Gita, gourmet cooking, working in nature, and caring for for the natural world.  

 

California Institute of Integral Studies:  

https://www.ciis.edu/research-centers/center-for-psychedelic-therapies-and-research/about-the-center-for-psychedelic-therapies-and-research

 

LinkedIn:  

https://www.linkedin.com/in/brian-richards-66a91210/

 

The Netflix docuseries ‘How to Change Your Mind’ by Michael Pollan
Features The Bill Richards Center for Healing in episode two, which focuses on psilocybin.   

https://www.netflix.com/title/80229847

 

A New Understanding: The Science of Psilocybin

https://www.youtube.com/watch?v=TIVIfQaqVG4

Publications

Selected Publications & Presentations

  • An international Delphi consensus for reporting of setting in psychedelic clinical trials 

Chloe Pronovost-Morgan, Kyle T. Greenway, Leor Roseman, The ReSPCT Experts, Brian Richards

Nature Medicine 2025

https://www.nature.com/articles/s41591-025-03685-9

 

  1. Assessment of Psilocybin Therapy for Patients with Cancer and Major Depression Disorder  Manish Agrawal MD, Ezekial Emanuel MD, PhD, Brian Richards Psy.D., William Richards Ph.D., Kim Roddy MBA, Paul Thambi MD

JAMA Oncology, Letters 

https://jamanetwork.com/journals/jamaoncology/article-abstract/2803623

  • Psilocybin-Assisted Group Therapy in Patients with Cancer Diagnosed with a Major Depressive Disorder

Manish Agrawal, William Richards, Yvan Beaussant, Sarah Schnayder, Rezvan Ameli, Kimberly Roddy, Norma Stevens, Brian Richards, Nick Schor, Heather Honstein, Betsy Jenkins, Mark Bates, Paul Thambi 

Cancer

https://pubmed.ncbi.nlm.nih.gov/38105655/

  • Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors

Griffiths, R.R., Johnson, M.W., Richards, W.A., Richards, B.D., Jesse, R., MacLean, K.A., Barrett, F.S., Cosimano, M.P., and Klinedinst, M.A.

Journal of Psychopharmacology (2017)

https://pubmed.ncbi.nlm.nih.gov/29020861/

  • A Guide to CPT and HCPCS Codes for Psychedelic-Assisted Therapy

BrainFutures

https://www.brainfutures.org/wp-content/uploads/2023/09/A-Guide-to-CPT-and-HCPCS-Codes-for-Psychedelic-Assisted-Therapy.pdf

  • An Expert-Informed Introduction to the Elements of Psychedelic-Assisted Therapy

https://www.brainfutures.org/wp-content/uploads/2022/10/An-Expert-Informed-Introduction-to-the-Elements-of-PAT_web.pdf

  • Expediting Psychedelic-Assisted Therapy Adoption in Clinical Settings

BrainFutures

https://www.brainfutures.org/wp-content/uploads/2022/05/BrainFutures_Expediting-Psychedelic-Assisted-Therapy-Adoption-in-Clinical-Settings.pdf

  • Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness

William E. Rosa, PhD, MBE, NP, Zachary Sager, MD, Megan Miller, PhD, RN, Ilan Bernstein, MD, Alden Doerner Rinaldi, MD, Katie Addicott, MSN, NP, Michael Ljuslin, MD, Chris Adrian, MD, Anthony L. Back, MD, Jamie Beachy, PhD, MDiv, Anthony P. Bossis, PhD, William S. Breitbart, MD, Mary P. Cosimano, LMSW, Stacy M. Fischer, MD, Jeffrey Guss, MD, Emma Knighton, MA, LMHC, Janis Phelps, PhD, Brian D. Richards, PsyD, William A. Richards, PhD, James A. Tulsky, MD, Monnica T. Williams, PhD, and Yvan Beaussant, MD

Journal of Palliative Medicine (2022)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467634/

  • Psychedelic Medicine: A Review of Clinical Research for a Class of Rapidly Emerging Behavioral Health Interventions

BrainFutures, March, 2022

https://www.brainfutures.org/wp-content/uploads/2022/05/BrainFutures-Psychedelic-Medicine-Report.pdf

 

  1. Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research

Sara J. Tai, Elizabeth M. Nielson, Molly Lennard-Jones,

Riikka-Liisa Johanna Ajantaival, Rachel Winzer, William A. Richards,

Frederick Reinholdt, Brian D. Richards, Peter Gasser and Ekaterina Malievskaia

Frontiers in Psychiatry (2021)

https://pubmed.ncbi.nlm.nih.gov/33643087/

  •  Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

 Griffiths, R.R., Johnson, M.W., Carducci, M.A., Umbricht, A., Richards, W.A., Richards, B.D., Cosimano M.R and Klinedinst, M.A.

 Journal of Psychopharmacology (2016) 

 Awarded 2020 Journal of Psychopharmacology Prize for having the highest number of citations of all original research articles published in Journal of Psychopharmacology in 2016.

 https://pubmed.ncbi.nlm.nih.gov/27909165/

  •  Characterization of Individuals Seeking Treatment for Caffeine Dependence 

 Juliano, L. M., Evatt, D. P., Richards, B. D., & Griffiths, R. R. 

 Psychology of Addictive Behaviors (2012)

 https://pubmed.ncbi.nlm.nih.gov/22369218/

  •    Psilocybin Occasioned Mystical-Type Experiences:  Immediate and Persisting Dose-Related Effects

   Roland R, Griffiths, Matthew W. Johnson, William A. Richards, Brian D. Richards, Una   

   McCann, Robert Jesse

               Psychopharmacology (2011)

               https://pubmed.ncbi.nlm.nih.gov/21674151/

 

  1.  Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects of Supratherapeutic Doses of Triazolam, Pentobarbital, and GHB
    Lawrence P. Carter, Brian D. Richards, Miriam Z Mintzer and Roland R Griffiths
    Neuropsychopharmacology (2006), 1-15

 https://pubmed.ncbi.nlm.nih.gov/16880774/

Ages

Adult (ages 18+)

Locations

Baltimore (Mt. Washington)

Services

KAP (Ketamine Assisted Psychotherapy) | Psychological Screening

Provider Types

Therapist

Areas of Special Interest

Assessment | Psychedelic Assisted Therapy
Cute Li'l Robot Icon

Hi! Welcome to Gladstone Psychiatry and Wellness. What brings you to our site today?